MODULATION OF MESOLIMBIC DOPAMINERGIC BEHAVIORS BY CHOLECYSTOKININ

被引:18
作者
CRAWLEY, JN
机构
关键词
D O I
10.1111/j.1749-6632.1988.tb42121.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:380 / 396
页数:17
相关论文
共 75 条
[1]   A DOUBLE-BLIND-STUDY WITH CERULETIDE IN CHRONIC-SCHIZOPHRENIC PATIENTS - BIOCHEMICAL AND CLINICAL-RESULTS [J].
ALBUS, M ;
VONGELLHORN, K ;
MUNCH, U ;
NABER, D ;
ACKENHEIL, M .
PSYCHIATRY RESEARCH, 1986, 19 (01) :1-7
[2]   INCREASE IN BRAIN I-125-LABELED CHOLECYSTOKININ (CCK) RECEPTOR-BINDING FOLLOWING CHRONIC HALOPERIDOL TREATMENT, INTRACISTERNAL 6-HYDROXYDOPAMINE OR VENTRAL TEGMENTAL LESIONS [J].
CHANG, RSL ;
LOTTI, VJ ;
MARTIN, GE ;
CHEN, TB .
LIFE SCIENCES, 1983, 32 (08) :871-878
[3]   PRESYNAPTIC REGULATION OF NEUROTRANSMITTER RELEASE IN THE BRAIN - FACTS AND HYPOTHESIS [J].
CHESSELET, MF .
NEUROSCIENCE, 1984, 12 (02) :347-375
[4]   PROGLUMIDE - SELECTIVE ANTAGONISM OF EXCITATORY EFFECTS OF CHOLECYSTOKININ IN CENTRAL NERVOUS-SYSTEM [J].
CHIODO, LA ;
BUNNEY, BS .
SCIENCE, 1983, 219 (4591) :1449-1450
[5]   EFFECTS OF SELECTIVE DOPAMINE-D2-RECEPTOR AGONISTS ON THE RELEASE OF CHOLECYSTOKININ-LIKE IMMUNOREACTIVITY FROM RAT NEOSTRIATUM [J].
CONZELMANN, U ;
HOLLAND, A ;
MEYER, DK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 101 (1-2) :119-125
[6]   DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN [J].
COSTALL, B ;
NAYLOR, RJ ;
CANNON, JG ;
LEE, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) :337-342
[7]   BEHAVIORAL AND NEUROPHYSIOLOGICAL EVIDENCE FOR A FACILATORY INTERACTION BETWEEN CO-EXISTING TRANSMITTERS - CHOLECYSTOKININ AND DOPAMINE [J].
CRAWLEY, JN ;
HOMMER, DW ;
SKIRBOLL, LR .
NEUROCHEMISTRY INTERNATIONAL, 1984, 6 (06) :755-760
[8]  
CRAWLEY JN, 1985, J NEUROSCI, V5, P1972
[9]   TOPOGRAPHICAL ANALYSIS OF NUCLEUS ACCUMBENS SITES AT WHICH CHOLECYSTOKININ POTENTIATES DOPAMINE-INDUCED HYPERLOCOMOTION IN THE RAT [J].
CRAWLEY, JN ;
HOMMER, DW ;
SKIRBOLL, LR .
BRAIN RESEARCH, 1985, 335 (02) :337-341
[10]  
CRAWLEY JN, 1986, J PHARMACOL EXP THER, V236, P320